1. Home
  2. PAYO vs PTGX Comparison

PAYO vs PTGX Comparison

Compare PAYO & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAYO
  • PTGX
  • Stock Information
  • Founded
  • PAYO 2005
  • PTGX 2006
  • Country
  • PAYO United States
  • PTGX United States
  • Employees
  • PAYO N/A
  • PTGX N/A
  • Industry
  • PAYO EDP Services
  • PTGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAYO Technology
  • PTGX Health Care
  • Exchange
  • PAYO Nasdaq
  • PTGX Nasdaq
  • Market Cap
  • PAYO 3.2B
  • PTGX 2.8B
  • IPO Year
  • PAYO N/A
  • PTGX 2016
  • Fundamental
  • Price
  • PAYO $8.66
  • PTGX $47.91
  • Analyst Decision
  • PAYO Strong Buy
  • PTGX Strong Buy
  • Analyst Count
  • PAYO 7
  • PTGX 7
  • Target Price
  • PAYO $8.93
  • PTGX $52.83
  • AVG Volume (30 Days)
  • PAYO 2.0M
  • PTGX 450.1K
  • Earning Date
  • PAYO 11-05-2024
  • PTGX 11-08-2024
  • Dividend Yield
  • PAYO N/A
  • PTGX N/A
  • EPS Growth
  • PAYO 447.53
  • PTGX N/A
  • EPS
  • PAYO 0.26
  • PTGX 2.75
  • Revenue
  • PAYO $900,058,000.00
  • PTGX $319,120,000.00
  • Revenue This Year
  • PAYO $14.06
  • PTGX $400.33
  • Revenue Next Year
  • PAYO $7.49
  • PTGX N/A
  • P/E Ratio
  • PAYO $32.93
  • PTGX $17.54
  • Revenue Growth
  • PAYO 21.43
  • PTGX 125.73
  • 52 Week Low
  • PAYO $4.22
  • PTGX $13.76
  • 52 Week High
  • PAYO $8.60
  • PTGX $48.89
  • Technical
  • Relative Strength Index (RSI)
  • PAYO 81.47
  • PTGX 60.40
  • Support Level
  • PAYO $8.27
  • PTGX $45.33
  • Resistance Level
  • PAYO $8.56
  • PTGX $48.89
  • Average True Range (ATR)
  • PAYO 0.16
  • PTGX 1.28
  • MACD
  • PAYO 0.02
  • PTGX 0.11
  • Stochastic Oscillator
  • PAYO 100.00
  • PTGX 77.11

About PAYO Payoneer Global Inc.

Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started to empower global commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Share on Social Networks: